OMEGA PHARMA

REHYDRAL OFTA 25 ML

REHYDRAL OFTA 25 ML

Skip to product information
1 of 1
  • Secure payment
  • Discreet and sanitized package
  • Fast and safe shipping

Description

Descriptive sheet

REHYDRAL OFTA

Description
Periocular lipogel with dermotrophic, soothing, emollient action.
Active ingredients: DNA-RNA nucleotides; hyaluronic acid; 4-terpineol (Malaleuca); aloe; chamomile (bisabolol); vitamin C (levorotatory ascorbic acid); vitamin E; hesperidin.

How to use
We recommend 2 applications per day, in the morning and in the evening on the area to be treated.
Rub the gel until completely absorbed.

Warnings
Product for external use only. It should not be swallowed or placed in contact with mucous membranes.

Conservation
Store at room temperature. Shelf life in unopened packaging: 24 months.

Format
25 ml.

Code 275

OMEGA PHARMA

REHYDRAL OFTA 25 ML

REHYDRAL OFTA 25 ML

MINSAN code: 980810497
Previous price: €19,53
Regular price €19,53
Regular price €0,00 Sale price €19,53
-% Sold out
Tax included. Shipping calculated at checkout.
View full details

Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.